From: Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model
Model | AUC (95% CI) | Accuracy | Precision | Recall | F1-Score |
---|---|---|---|---|---|
training set: | |||||
   Clinical | 0.89 (0.81–0.95) | 0.81 | 0.80 | 0.96 | 0.88 |
   TNM | 0.46(0.25–0.68) | 0.73 | 0.73 | 0.96 | 0.83 |
   CTV | 0.89 (0.80–0.96) | 0.83 | 0.81 | 0.99 | 0.88 |
   GTV | 0.83 (0.72–0.93) | 0.76 | 0.73 | 1.0 | 0.85 |
   CTV-Clinical | 0.67 (0.56–0.78) | 0.76 | 0.76 | 0.94 | 0.84 |
   GTV-Clinical | 0.99 (0.98–0.99) | 0.96 | 0.94 | 1.0 | 0.97 |
testing set: | |||||
   Clinical | 0.80 (0.60–0.96) | 0.75 | 0.72 | 1.0 | 0.84 |
   TNM | 0.64 (0.51–0.77) | 0.54 | 0.62 | 0.71 | 0.70 |
   CTV | 0.70(0.43–0.94) | 0.63 | 0.67 | 0.88 | 0.76 |
   GTV | 0.77 (0.53–0.96) | 0.75 | 0.75 | 0.94 | 0.83 |
   CTV-Clinical | 0.56 (0.4–0.75) | 0.67 | 0.70 | 0.86 | 0.78 |
   GTV-Clinical | 0.82 (0.66–0.99) | 0.71 | 0.74 | 0.88 | 0.80 |
validation set: | |||||
   Clinical | 0.82 (0.57–1.0) | 0.55 | 0.44 | 1.0 | 6.15 |
   TNM | 0.80 (0.50–1.0) | 0.64 | 0.50 | 1.0 | 0.67 |
   CTV | 0.68 (0.25–1.0) | 0.45 | 0.4 | 1.0 | 0.57 |
   GTV | 0.91 (0.67–1.0) | 0.73 | 0.57 | 1.0 | 0.73 |
   CTV-Clinical | 0.57 (0.50–0.75) | 0.54 | 0.44 | 1.0 | 0.62 |
   GTV-Clinical | 0.97 (0.84–1.0) | 0.72 | 0.57 | 1.0 | 0.73 |